Huaren Pharmaceutical Co., Ltd. (SHE:300110)

Huaren Pharmaceutical Revenue

Huaren Pharmaceutical had revenue of 309.97M CNY in the quarter ending March 31, 2026, with 2.14% growth. This brings the company's revenue in the last twelve months to 1.33B, up 6.24% year-over-year. In the year 2025, Huaren Pharmaceutical had annual revenue of 1.32B, down -2.34%.

• Revenue (ttm): 1.33B
• Revenue Growth: +6.24%
• P/S Ratio: 2.80
• Revenue / Employee: 533.10K
• Employees: 2,491
• Market Cap: 3.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.32B	-31.71M	-2.34%
Dec 31, 2024	1.35B	-283.09M	-17.30%
Dec 31, 2023	1.64B	16.76M	1.04%
Jan 1, 2023	1.62B	58.64M	3.76%
Jan 1, 2022	1.56B	244.26M	18.55%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error